Praluent Alternatives Compared
Praluent | Atorvastatin | Simvastatin |
|
---|
Praluent (alirocumab) | Atorvastatin | Simvastatin |
|
|||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Praluent is a PCSK9 inhibitor that may be used to reduce LDL-C levels in people with primary hyperlipidemia, genetically high cholesterol, or to reduce the risk of a heart attack, stroke, or... View more |
Prescription only
Atorvastatin is effective at lowering cholesterol; however, its use may be limited by side effects such as muscle pain. Prescribed for High Cholesterol, High Cholesterol - Familial Heterozygous... View more |
Prescription only
Simvastatin is effective at lowering cholesterol; however, it may cause muscle pain, particularly at higher dosages. Should not be used by people with active liver disease or in women planning a... View more |
Related suggestions High Cholesterol
High Cholesterol, Familial Heterozygous
High Cholesterol, Familial Homozygous
Popular comparisons
|
|||||||||||||||||||||||
More about Praluent (alirocumab) | More about Atorvastatin | More about Simvastatin | ||||||||||||||||||||||||
Ratings & Reviews | ||||||||||||||||||||||||||
Praluent has an average rating of 6.3 out of 10 from a total of 282 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 32% reported a negative effect. |
Atorvastatin has an average rating of 4.3 out of 10 from a total of 294 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 56% reported a negative effect. |
Simvastatin has an average rating of 4.8 out of 10 from a total of 130 ratings on Drugs.com. 31% of reviewers reported a positive effect, while 50% reported a negative effect. |
||||||||||||||||||||||||
Drug Class | ||||||||||||||||||||||||||
Side Effects | ||||||||||||||||||||||||||
See also: Praluent side effects in more detail. |
See also: atorvastatin side effects in more detail. |
See also: simvastatin side effects in more detail. |
||||||||||||||||||||||||
Generic Availability | ||||||||||||||||||||||||||
N/A |
Lower cost generic |
Lower cost generic |
||||||||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all Praluent prices |
View all atorvastatin prices |
View all simvastatin prices |
||||||||||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
Brand Names | ||||||||||||||||||||||||||
N/A |
Atorvaliq, Lipitor | FloLipid, Zocor | ||||||||||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
480 hours |
14 hours |
N/A |
||||||||||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
Pregnancy Category | ||||||||||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||||||||||||||||||
Drug Interactions | ||||||||||||||||||||||||||
A total of 2 drugs are known to interact with Praluent:
|
A total of 375 drugs are known to interact with atorvastatin:
|
A total of 311 drugs are known to interact with simvastatin:
|
||||||||||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
Disease Interactions | ||||||||||||||||||||||||||
No known disease interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||||
First Approval Date | ||||||||||||||||||||||||||
July 24, 2015 |
December 17, 1996 |
December 23, 1991 |
||||||||||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||||||||||
More Information | ||||||||||||||||||||||||||
Patient resources | ||||||||||||||||||||||||||
Professional Resources | ||||||||||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||||||||||
|
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.